Medroxalol
Product Specifications
UNSPSC Description
Medroxalol (RMI81968) is an orally active adrenergic receptor antagonist, blocks α- and β-adrenergic receptors. Medroxalol shows antihypertensive and vasodilating effects[1].
Target Antigen
Adrenergic Receptor
Type
Reference compound
Related Pathways
GPCR/G Protein;Neuronal Signaling
Applications
Neuroscience-Neuromodulation
Field of Research
Cardiovascular Disease
Assay Protocol
https://www.medchemexpress.com/medroxalol.html
Purity
99.66
Solubility
DMSO : 50 mg/mL (ultrasonic)
Smiles
O=C(N)C1=CC(C(O)CNC(C)CCC2=CC=C(OCO3)C3=C2)=CC=C1O
Molecular Weight
372.41
References & Citations
[1]Dage RC, et al. Cardiovascular properties of medroxalol, a new antihypertensive drug. J Cardiovasc Pharmacol. 1981 Mar-Apr;3(2):299-315.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-101656/Medroxalol-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-101656/Medroxalol-SDS-MedChemExpress.pdf
Clinical Information
No Development Reported
CAS Number
56290-94-9
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
CSB-EP364095ENV-01 20 µg
Recombinant Escherichia coli Crossover junction endodeoxyribonuclease RuvC (ruvC)
Ask
View Details 
CSB-EP364095ENV-02 100 µg
Recombinant Escherichia coli Crossover junction endodeoxyribonuclease RuvC (ruvC)
Ask
View Details CSB-EP364095ENV-03 1 mg
Recombinant Escherichia coli Crossover junction endodeoxyribonuclease RuvC (ruvC)
Ask
View Details